Leukeran 5mg Tablets Australia - English - Department of Health (Therapeutic Goods Administration)

leukeran 5mg tablets

aspen pharmacare australia pty ltd - chlorambucil, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; sucrose; quinoline yellow; magnesium stearate - treatment of hodgkin's disease, certain forms of non-hodgkin's lymphoma, chronic lymphocytic leukaemia, waldenstrom's macroglobulinaemia, advanced ovarian adenocarcinoma. leukeran has a significant effect in a proportion of patients with breast cancer.

Leukeran New Zealand - English - Medsafe (Medicines Safety Authority)

leukeran

pharmacy retailing (nz) ltd t/a healthcare logistics - chlorambucil 5mg - tablet - 5 mg - active: chlorambucil 5mg excipient: lactose monohydrate   magnesium stearate   pregelatinised maize starch   quinoline yellow starch sucrose

LEUKERAN TABLETS 2 MG Israel - English - Ministry of Health

leukeran tablets 2 mg

padagis israel agencies ltd, israel - chlorambucil - tablets - chlorambucil 2 mg - chlorambucil - leukeran is indicated in the treatment of hodgkin's disease, indolent non-hodgkin's lymphoma, chronic lymphocytic leukaemia, and waldenstrom's macroglobulinaemia

LEUKERAN TABLET 2 mg (Revised Formula) Singapore - English - HSA (Health Sciences Authority)

leukeran tablet 2 mg (revised formula)

dch auriga singapore - chlorambucil - tablet, film coated - 2 mg - chlorambucil 2 mg

LEUKERAN chlorambucil 2mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

leukeran chlorambucil 2mg tablet bottle

aspen pharmacare australia pty ltd - chlorambucil, quantity: 2 mg - tablet, film coated - excipient ingredients: lactose; microcrystalline cellulose; stearic acid; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of hodgkin's disease, certain forms of non-hodgkin's lymphoma, chronic lymphocytic leukaemia, waldenstrom's macroglobulinaemia, advanced ovarian adenocarcinoma. leukeran has a significant effect in a proportion of patients with breast cancer

Leukeran New Zealand - English - Medsafe (Medicines Safety Authority)

leukeran

pharmacy retailing (nz) ltd t/a healthcare logistics - chlorambucil 2mg (+ 5% manufacturing overage) - tablet - 2 mg - active: chlorambucil 2mg (+ 5% manufacturing overage) excipient: colloidal silicon dioxide ethanol lactose monohydrate microcrystalline cellulose opadry brown 05b26836 purified water stearic acid

Leukeran 2 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

leukeran 2 mg film-coated tablets

aspen pharma trading limited - chlorambucil - film-coated tablet - 2 milligram(s) - nitrogen mustard analogues; chlorambucil

Leukeran 2mg film coated Tablets Malta - English - Medicines Authority

leukeran 2mg film coated tablets

aspen pharma trading limited 3016 lake drive city west businees campus dublin 24, ireland - chlorambucil - film-coated tablet - chlorambucil 2 mg - antineoplastic agents